Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 5.1 Opinion of Walkers Cayman LLP
- 10.8 Form of Subscription Agreement
- 10.12 Clinical and Commercial Manufacturing Agreement, Dated April 11, 2022, Effective July 1, 2021, by and Between Moonlake Immunotherapeutics Ag and Richter-helm Biologics GMBH & Co. KG
- 23.1 Consent of Withumsmith+brown, PC.
- 23.2 Consent of Baker Tilly Us, LLP.
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 5 May 23 EFFECT Notice of effectiveness
- 1 May 23 POS AM Prospectus update (post-effective amendment)
- 28 Mar 23 424B3 Prospectus supplement
- 28 Mar 23 EFFECT Notice of effectiveness
- 20 Mar 23 POS AM Prospectus update (post-effective amendment)
- 14 Nov 22 424B3 Prospectus supplement
- 12 Aug 22 424B3 Prospectus supplement
- 3 Aug 22 EFFECT Notice of effectiveness
- 2 Aug 22 424B3 Prospectus supplement
- 26 Jul 22 S-1/A IPO registration (amended)
- 15 Jul 22 S-1/A IPO registration (amended)
-
2 May 22 S-1/A IPO registration (amended)
- 14 Mar 22 S-1/A IPO registration (amended)
- 8 Mar 22 S-1/A IPO registration (amended)
- 11 Feb 22 S-1 IPO registration
MLTX similar filings
Filing view
External links